HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Allergy & Immunology
Meta-analysis
Systematic review and meta-analysis of stem cell therapy for dry eye in Sjögren's syndrome
Stem Cell Therapy Eases Dry Eye in Sjögren’s Syndrome Patients
This systematic review and meta-analysis evaluated stem cell therapy for patients with dry eye syndrome caused by Sjögren's syndrome. The an…
New analysis shows stem cell therapy eases dry eye pain and improves tear flow for people with Sjögren’s syndrome.
Frontiers
Apr 29, 2026
Allergy & Immunology
Cohort
Anti-centromere antibody-positive Sjögren's syndrome profile predicted by serologic and clinical factors
New Tool Predicts Hidden Risk in Sjögren’s Patients
This retrospective observational cohort study developed a predictive model for anti-centromere antibody-positive Sjögren's syndrome in 616 p…
Dry eyes. Dry mouth. Fatigue. For many with Sjögren’s syndrome, these are daily struggles.
Frontiers
Apr 24, 2026
Nephrology
Meta-analysis
Physical activity improves cardiopulmonary function and general health in individuals with Sjögren's syndrome.
Physical activity linked to better health and function in Sjögren's syndrome patients
This systematic review and meta-analysis of randomized controlled trials evaluated physical activity versus controls in 277 participants wit…
For people with Sjögren's syndrome, physical activity improves heart and lung function, energy, and mental health, though it does not clearl…
Frontiers
Apr 13, 2026
Rheumatology
Cohort
Reduced anti-CXCR3 antibodies associated with systemic autoimmunity and atherosclerosis in cohort study
Study finds link between specific antibody levels and heart disease risk in autoimmune conditions
An observational cohort study of patients with rheumatoid arthritis, Sjogren disease, and controls found reduced anti-CXCR3 antibody levels …
Low levels of a specific antibody in early arthritis and joint pain are linked to higher heart disease risk and poorer medication responses.
medRxiv
Apr 4, 2026
Diabetes & Endocrinology
Sys. Review
Rituximab with prednisone reduced proteinuria in Sjögren's syndrome-associated membranous nephropathy case
Rituximab treatment reduced kidney protein loss in one Sjögren's syndrome patient
A case report describes a 48-year-old female with primary Sjögren's syndrome and nephrotic-range proteinuria treated with prednisone and rit…
A 48-year-old woman with Sjögren's syndrome saw her kidney protein loss drop from 8.5 to 2.2 grams after receiving rituximab treatment.
Frontiers
Apr 3, 2026